Wall Street Analysts See Booking Holdings (BKNG) as a Buy: Should You Invest?

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 25th:

Revolve Group, Inc. RVLV: This online fashion retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.

Revolve Group, Inc. price-consensus-chart | Revolve Group, Inc. Quote

Revolve’s shares gained 4.8% over the past month compared with the S&P 500’s advance of 3.7%. The company possesses a Momentum Score  of A.

Revolve Group, Inc. price | Revolve Group, Inc. Quote

Pharming Group N.V. PHAR: This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days.

Pharming Group N.V. Sponsored ADR price-consensus-chart | Pharming Group N.V. Sponsored ADR Quote

Pharming’s shares gained 19.8% over the last three months compared with the S&P 500’s advance of 15.2%. The company possesses a Momentum Score of B.

Pharming Group N.V. Sponsored ADR price | Pharming Group N.V. Sponsored ADR Quote

Amazon.com, Inc. AMZN: This online retail giant has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

Amazon.com, Inc. price-consensus-chart | Amazon.com, Inc. Quote

Amazon’s shares gained 23.8% over the last three months compared with the S&P 500’s advance of 15.2%. The company possesses a Momentum Score of A.

Amazon.com, Inc. price | Amazon.com, Inc. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amazon.com, Inc. (AMZN) : Free Stock Analysis Report

Revolve Group, Inc. (RVLV) : Free Stock Analysis Report

Pharming Group N.V. Sponsored ADR (PHAR) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Scroll to Top